A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination

被引:9
|
作者
Experton, Bettina [1 ]
Tetteh, Hassan A. [2 ]
Lurie, Nicole [3 ,4 ]
Walker, Peter [5 ]
Elena, Adrien [1 ]
Hein, Christopher S. [1 ]
Schwendiman, Blake [1 ]
Vincent, Justin L. [6 ]
Burrow, Christopher R. [1 ]
机构
[1] Humetrix Inc, Del Mar, CA 90214 USA
[2] Dept Def Joint Artificial Intelligence Ctr JAIC, Warfighter Hlth Mission Team, Arlington, VA 22202 USA
[3] Coalit Epidem Preparedness Innovat CEPI, Washington, DC 20006 USA
[4] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[5] US Navy, Washington, DC 20376 USA
[6] Amazon Web Serv Inc, Seattle, WA 98109 USA
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 11期
关键词
COVID-19 vaccine prioritization; COVID-19 booster vaccine; severe COVID-19 disease; risk for severe COVID-19 infection; COVID-19 vaccine booster prioritization; Medicare population; severe COVID-19 risk model;
D O I
10.3390/biology10111185
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple SummaryWhether it is for COVID-19 primary vaccination or the administration of booster vaccines, prioritization criteria need to be established to optimize COVID-19 vaccination programs accounting for both clinical and social vulnerability risks for severe COVID-19 disease. We developed a dual socio-clinical risk model for severe COVID-19 disease in the Medicare population, which is comprised mostly of individuals aged 65 and over. Our model generated risk levels correlated with regionalized COVID-19 case hospitalization rates and mapped them at the county and zip code levels. The model and map can be used by health jurisdictions to reach out to unvaccinated individuals. Our model approach can also be applied to identify Medicare beneficiaries who were in early vaccination groups to be vaccinated to identify those who might maximally benefit from an additional dose of COVID-19 vaccine if and when vaccine immunity wanes.Recommendations for prioritizing COVID-19 vaccination have focused on the elderly at higher risk for severe disease. Existing models for identifying higher-risk individuals lack the needed integration of socio-demographic and clinical risk factors. Using multivariate logistic regression and random forest modeling, we developed a predictive model of severe COVID-19 using clinical data from Medicare claims for 16 million Medicare beneficiaries and socio-economic data from the CDC Social Vulnerability Index. Predicted individual probabilities of COVID-19 hospitalization were then calculated for population risk stratification and vaccine prioritization and mapping. The leading COVID-19 hospitalization risk factors were non-white ethnicity, end-stage renal disease, advanced age, prior hospitalization, leukemia, morbid obesity, chronic kidney disease, lung cancer, chronic liver disease, pulmonary fibrosis or pulmonary hypertension, and chemotherapy. However, previously reported risk factors such as chronic obstructive pulmonary disease and diabetes conferred modest hospitalization risk. Among all social vulnerability factors, residence in a low-income zip code was the only risk factor independently predicting hospitalization. This multifactor risk model and its population risk dashboard can be used to optimize COVID-19 vaccine allocation in the higher-risk Medicare population.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Cutaneous manifestations of COVID-19 and COVID-19 vaccination
    Nakashima, Chisa
    Kato, Maiko
    Otsuka, Atsushi
    JOURNAL OF DERMATOLOGY, 2023, 50 (03): : 280 - 289
  • [22] Covid-19: Booster vaccination reduces hospitalizations for IBD
    Simon, Annika
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (09):
  • [23] COVID-19 in children and the importance of COVID-19 vaccination
    Feng-Xia Xue
    Kun-Ling Shen
    World Journal of Pediatrics, 2021, 17 : 462 - 466
  • [24] Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination
    De Michele, Manuela
    Kahan, Joshua
    Berto, Irene
    Schiavo, Oscar G.
    Iacobucci, Marta
    Toni, Danilo
    Merkler, Alexander E.
    CIRCULATION RESEARCH, 2022, 130 (08) : 1187 - 1203
  • [25] COVID-19 in children and the importance of COVID-19 vaccination
    Xue, Feng-Xia
    Shen, Kun-Ling
    WORLD JOURNAL OF PEDIATRICS, 2021, 17 (05) : 462 - 466
  • [26] COVID-19 despite full COVID-19 vaccination
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (05)
  • [27] Myopericarditis After COVID-19 Booster Dose Vaccination
    Sharff, Katie A.
    Dancoes, David M.
    Longueil, Jodi L.
    Lewis, Paul F.
    Johnson, Eric S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 172 : 165 - 166
  • [28] Hypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination
    Ebinger, Joseph E.
    Driver, Matthew
    Joung, Sandy
    Tran, Teresa
    Barajas, Denisse
    Wu, Min
    Botting, Patrick G.
    Navarrette, Jesse
    Sun, Nancy
    Cheng, Susan
    HYPERTENSION, 2022, 79 (10) : E132 - E134
  • [29] Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection
    Gilboa, Mayan
    Regev-Yochay, Gili
    Mandelboim, Michal
    Indenbaum, Victoria
    Asraf, Keren
    Fluss, Ronen
    Amit, Sharon
    Mendelson, Ella
    Doolman, Ram
    Afek, Arnon
    Freedman, Laurence S.
    Kreiss, Yitshak
    Lustig, Yaniv
    JAMA NETWORK OPEN, 2022, 5 (09) : E2231778
  • [30] Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals
    Su, Bin
    Vanham, Guido
    AIDS, 2023, 37 (05) : 837 - 839